IPF is progressive. This means that the scarring caused by IPF will continue to happen, and lung function will continue to get worse
IPF is unpredictable. It is difficult to know how slowly or quickly IPF will progress. Each person's experience is different
IPF is irreversible. Once there is scarring in the lungs, it cannot be reversed. Today, there is no cure for IPF, but there are treatment options that may slow its progression
Ask your doctor about the progression of IPF over time
IPF is progressive, which means that over time the scarring becomes more widespread and lung function declines. IPF progresses rapidly for some people and slowly for others
This scarring, or fibrosis, may be the result of tiny injuries deep in your lungs that do not heal properly.
These injuries lead to progressive scarring of tissue in the small air sacs in your lungs (called alveoli). This scarring, or fibrosis, causes the lungs to stiffen.
Fibrosis may damage the lungs' ability to exchange gases such as oxygen with the blood.
Did you know that the average lung function loss in adults without IPF is 30 mL/year? But in idiopathic pulmonary fibrosis (IPF), the progressive scarring in the lung can lead to much greater annual loss.
Currently, there is no cure for IPF, but there are treatment options that may help delay disease progression.
I want people to realize that IPF is just a disease. The diagnosis is not the end; it is the beginning-the beginning of personal development, potential, and change."
Janet
Esbriet Ambassador
Centers for Medicare & Medicaid Services. Advance notice of methodological changes for calendar year (CY) 2018 for Medicare Advantage (MA) capitation rates, Part C and Part D payment policies and 2018 call letter. https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Advance2018.pdf. Posted February 1, 2017. Accessed October 17, 2017.
Centers for Medicare & Medicaid Services. Advance notice of methodological changes for calendar year (CY) 2018 for Medicare Advantage (MA) capitation rates, Part C and Part D payment policies and 2018 call letter. https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Advance2018.pdf. Posted February 1, 2017. Accessed October 17, 2017.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.